checkAd
    Startseite > Aktien > Kane Biotech > Nachrichten
    Kane Biotech Aktie
    0,1350
     
    CAD
    +8,00 %
    +0,0100 CAD
    Letzter Kurs 15.05.24 TSX Venture
    0,1300
     
    CAD
    10.000 STK
    Geldkurs 10:00:09
    0,1400
     
    CAD
    43.500 STK
    Briefkurs 10:00:09
    ISIN: CA4838092084 · WKN: A2DNC4 · SYM: KNE · Kanada

    Neueste Nachrichten

    Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
    15.05.24 · globenewswire · Kane Biotech
    Kane Biotech to Host Investor Webinar
    16.04.24 · globenewswire · Kane Biotech
    Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
    15.04.24 · globenewswire · Kane Biotech
    Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
    11.04.24 · globenewswire · Kane Biotech
    Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results
    26.03.24 · globenewswire · Kane Biotech
    Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
    20.03.24 · globenewswire · Kane Biotech
    Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
    19.03.24 · globenewswire · Kane Biotech
    Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
    08.03.24 · globenewswire · Kane Biotech
    Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
    22.02.24 · globenewswire · Kane Biotech
    Kane Biotech Files New Patent on revyve Antimicrobial Wound Gel Spray
    31.01.24 · globenewswire · Kane Biotech
    Kane Biotech to Present its revyve Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
    25.01.24 · globenewswire · Kane Biotech
    Kane Biotech Announces Special Meeting of Shareholders
    18.01.24 · globenewswire · Kane Biotech